The Regulatory Readiness Playbook for Life Sciences

[Article Title]

The regulatory world has changed, and it feels like everything changed at once. The Quality Management System Regulation (QMSR) took effect February 2, 2026, aligning U.S. Food and Drug Administration (FDA) medical device quality requirements with ISO 13485 for the first time. The FDA's Computer Software Assurance (CSA) guidance was revised in September 2025 and again in February 2026, replacing the old validation paradigm with a risk-based, least-burdensome model. Revised drafts of EU GMP Chapter 4 and Annex 11, along with the new Annex 22 on artificial intelligence (AI), were published for stakeholder consultation in July 2025, and the European Medicines Agency (EMA) is expected to formally adopt all three in 2026.

Remote audits have been normalized. AI tools, both in your operations and in the FDA's, are changing the very definition of “compliance”. Download this handbook from Master Control for a strategic operating guide that walks you through exactly what has changed, what regulators are inspecting for, and how AI is reshaping both sides of the compliance equation.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the phone number you would like to be contacted at.

    Please enter the e-mail address you would like to be contacted at.

  • Please enter the name of the company or institution you work at.

    Please select your job area.

  • Please select your country.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.